Results 241 to 250 of about 315,886 (312)

Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma

open access: yesExploration, EarlyView.
An acid‐cleavable Tf‐modified engineering exosome‐based brain‐targeting delivery system (ACTE) was proposed using metabolic glycoengineering and bioorthogonal click chemistry, enabling co‐delivery of siTGF‐β and DOX for GBM treatment. ACTE was featured by higher BBB transcytosis efficiency and hierarchical targeting delivery to GBM cells.
Jun Yang   +14 more
wiley   +1 more source

Harnessing the Potential of Exosomes in Therapeutic Interventions for Brain Disorders. [PDF]

open access: yesInt J Mol Sci
Bai L   +10 more
europepmc   +1 more source

Synthetic Biology‐Based Engineering Cells for Drug Delivery

open access: yesExploration, EarlyView.
Synthetic biology‐based therapeutic cells for drug delivery: Engineered cells effectively transport and release drugs through their intelligence and controllability, such as feedback pathways and external stimuli (e.g., light and ultrasound). The integration of nanotechnology, including nanoparticles, biofilms, and artificial cells, enhances ...
Wenzhe Yi   +4 more
wiley   +1 more source

Exosome isolation and characterization for advanced diagnostic and therapeutic applications. [PDF]

open access: yesMater Today Bio
Mukerjee N   +10 more
europepmc   +1 more source

Engineered Exosome‐Based Senolytic Therapy Alleviates Stroke by Targeting p21+CD86+ Microglia

open access: yesExploration, EarlyView.
We identified a harmful immune cell type, p21+CD86+ microglia, driving post‐stroke inflammation and developed a targeted exosome‐based therapy (Que@micro‐Exo) to eliminate these cells. This innovative treatment reduced inflammation, alleviated brain damage, and improved recovery in stroke models, offering a promising strategy for stroke and other ...
Jialei Yang, Shipo Wu, Miao He
wiley   +1 more source

Home - About - Disclaimer - Privacy